MDT Stock Recent News
MDT LATEST HEADLINES
Medtronic expects its fiscal 2025 third-quarter revenues to reflect an unfavorable impact of 1% from currency translation.
In the closing of the recent trading day, Medtronic (MDT) stood at $91.69, denoting a +0.79% change from the preceding trading day.
Three companies that are better positioned to withstand Trump's tariff challenges are ResMed, Hims & Hers Health and Medtronic.
GALWAY, Ireland , Feb. 5, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that it will report financial results for its third quarter of fiscal year 2025 on Tuesday, February 18, 2025. A news release will be issued at approximately 5:45 a.m.
Dublin, Feb. 03, 2025 (GLOBE NEWSWIRE) -- The "North America Balloon Sinuplasty Systems Market Outlook to 2033" report has been added to ResearchAndMarkets.com's offering. The comprehensive databook report covers key market data on the North America Balloon Sinuplasty Systems market. The databook report provides value (USD), volume (units) and average prices (USD) within the Balloon Sinuplasty Systems market segment. The North America Balloon Sinuplasty Systems Market report provides key information and data on:
I'm loading my retirement account with dividend stocks. The thesis is simple: Dividend stocks have historically outperformed non-dividend payers by more than 2-to-1 over the past 50 years and have been much less volatile.
In the most recent trading session, Medtronic (MDT) closed at $91.99, indicating a +0.63% shift from the previous trading day.
It takes money to make money. However, you don't need a lot to get started.
Shares of Medtronic (MDT 0.32%) are off to a fantastic start in 2025, already rising by 13% year to date. The medical devices giant had some weakness in recent years amid disappointing trends from its diabetes segment, but it appears to have finally turned the corner with its increasingly diversified operating profile.
When you're buying income stocks, a company's underlying business is arguably still the most crucial factor to consider, even more than the dividend yield. Corporations with high yields may look attractive, but sometimes these are unsustainable.